borna knowledge-based company has started its activity since 2013 in the field of pharmaceutical and medical biotechnology. With the aim of producing new pharmaceutical products based on recombinant proteins and biosimilar drugs, this company has always taken a step towards progress. With the use of capable experts in the research and development department and localization of all production stages, Daro Derman Brena plays an effective role in meeting the domestic demand for biological and biosimilar drugs.

In addition, by developing export capacities, this company seeks to expand its presence in international markets and improve Iran's position in the global pharmaceutical industry. Focusing on quality and innovation has made borna one of the pioneers in this field.